Zhangzhou Pientzehuang Pharmaceutical., Ltd

SHSE:600436 Stock Report

Market Cap: CN¥142.4b

Zhangzhou Pientzehuang Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jin Ming Huang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure5.3yrs

Recent management updates

Recent updates

Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Share Price Could Signal Some Risk

Nov 25
Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Share Price Could Signal Some Risk

These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely

Nov 07
These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely

Earnings Beat: Zhangzhou Pientzehuang Pharmaceutical., Ltd Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Oct 22
Earnings Beat: Zhangzhou Pientzehuang Pharmaceutical., Ltd Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Estimating The Intrinsic Value Of Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436)

Sep 08
Estimating The Intrinsic Value Of Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436)

Earnings Miss: Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By 39% And Analysts Are Revising Their Forecasts

Aug 20
Earnings Miss: Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By 39% And Analysts Are Revising Their Forecasts

Subdued Growth No Barrier To Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Price

Jul 12
Subdued Growth No Barrier To Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Price

These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely

May 27
These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely

Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price

Feb 28
Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price

CEO

Jin Ming Huang (58 yo)

5.3yrs

Tenure

CN¥601,700

Compensation

Mr. Jin Ming Huang is GM & Director of Zhangzhou Pientzehuang Pharmaceutical., Ltd from July 2019. He joined the Zhangzhou Pientzehuang Pharmaceutical., Ltd in September 2006. Mr. Huang served as President...


Board Members

NamePositionTenureCompensationOwnership
Jin Ming Huang
GM & Director5.3yrsCN¥601.70kno data
Haipeng Yang
Chief Accountant & Directorno dataCN¥529.50kno data
Cong Sheng Liu
Deputy GM & Directorno dataCN¥529.50kno data
Jin Cheng Chen
Chairman of the Supervisory Committee2.4yrsCN¥207.60kno data
Jianjun Jia
Independent Director7.3yrsCN¥80.00kno data
Dong Ming Hong
Directorno dataCN¥444.50kno data
Guang Pei Li
Independent Director7.3yrsCN¥80.00kno data
Zhi Peng Fan
Independent Director6.7yrsCN¥80.00kno data
Tengyun Wei
Supervisor2.8yrsno datano data
Hong Kai Xu
Member of the Supervisory Board7.2yrsno datano data
Shouying Du
Independent Director2.8yrsCN¥80.00kno data
Huang Yalong
Employee Supervisor2.8yrsno datano data

5.3yrs

Average Tenure

56.5yo

Average Age

Experienced Board: 600436's board of directors are considered experienced (5.3 years average tenure).